Kodiak Sciences Inc (KOD)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Victor Perlroth |
Employees: | 90 |
Web site: | kodiak.com |
1200 PAGE MILL RD, PALO ALTO, CA, 94304
650-281-0850
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD) The company was formerly known as Oligasis, LLC.
Please log in first to see chart